BioCatalystWatch
NVCTWorkspace / NVCT / OverviewCompany library
Nuvectis Pharma, Inc. logo

Nuvectis Pharma, Inc.

Nuvectis Pharma, Inc. (NVCT)

Website

Price
Market cap
Next catalystPNH Phase 3 data presentations at ASH, December 2026nxp100 · Phase 3 dataCompany presentation ↗
Cash

Chart & Events

Candle interval

Core Clinical

Ciprocopan

Factor B

PreINDP1P2P3FilingApproved
Upcoming / outlook

Ciprocopan

Factor B

PreINDP1P2P3FilingApproved
Upcoming / outlook

Ciprocopan

Factor B

PreINDP1P2P3FilingApproved
Upcoming / outlook

Technology Summary

Scientific context

Detailed technology interpretation

Technology advantages

Representative pipeline applications

Disease and market context

Detailed science focus

Background, answer, next evidence

Clinical

Upcoming clinical milestones

Ciprocopan

Factor B

PreINDP1P2P3FilingApproved
Upcoming / outlook

Ciprocopan

Factor B

PreINDP1P2P3FilingApproved
Upcoming / outlook

Ciprocopan

Factor B

PreINDP1P2P3FilingApproved
Upcoming / outlook

Other pipelines

Ciprocopan

Factor B

PreINDP1P2P3FilingApproved
Ciprocopan

Factor B

BRAF

PreINDP1P2P3FilingApproved

BRAF

PreINDP1P2P3FilingApproved

BRAF

PreINDP1P2P3FilingApproved

BRAF

PreINDP1P2P3FilingApproved

BRAF

PreINDP1P2P3FilingApproved

BRAF

PreINDP1P2P3FilingApproved
NXP900

SRC × YES1

PreINDP1P2P3FilingApproved
NXP900

SRC × YES1

PreINDP2P3FilingApproved
Upcoming / outlook

NXP900

Small molecule

SRC × YES1

Approved / commercial

Ciprocopan

Factor B

PreINDP1P2P3FilingApproved

History / paused

GCN2

PreINDP1P2P3FilingApproved

GCN2

PreINDP1P2P3FilingApproved
Ciprocopan

Factor B

PreINDP1P2P3FilingApproved

BRAF

PreINDP1P2P3FilingApproved

BRAF

Financial position

Short-term investments

Net operating cash flow

Source and basis

Company funding outlook

Upcoming milestones

Company funding outlook

Financial history

Amounts and sources
PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing



PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing




PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Annual trends

Reported item

Reported shares and borrowings

Source and basis

Source and basis

Source and basis

Source and basis

Ownership and institutions

Status

Market Reaction / Supply Context

Market Structure

NVCT PR & News

PR & News

NVCT SEC archive